NCT03275233

Brief Summary

Psychiatric comorbidities in patient with Painful Peripheral neuropathy

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Sep 2019

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 29, 2017

Completed
9 days until next milestone

First Posted

Study publicly available on registry

September 7, 2017

Completed
2 years until next milestone

Study Start

First participant enrolled

September 4, 2019

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 4, 2020

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

January 4, 2021

Completed
Last Updated

April 22, 2019

Status Verified

January 1, 2019

Enrollment Period

4 months

First QC Date

August 29, 2017

Last Update Submit

April 19, 2019

Conditions

Painful Peripheral Neuropathy

Outcome Measures

Primary Outcomes (1)

  • Psychiatric comorbidities in diabetic patients with painful(symptomatic)peripheral neuropathy.

    1- Pain assessment using visual analogue scale (VAS).

    6 month

Eligibility Criteria

Age18 Years - 66 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Patients with painful peripheral neuropathy

You may qualify if:

  • Any female or male diabetic patient is aged 18 years or above had diabetic peripheral neuropathy.
  • patients must be able to swallow tables

You may not qualify if:

  • Patients have other comorbid psychiatric disorders or psychological troubles that is not secondary to diabetic neuropathy according to clinical and psychiatric evaluation,
  • Patients have any other causes of pain condition, or had skin conditions that are likely to confound the assessment of diabetic peripheral neuropathic pain.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Central Study Contacts

Noha Mohamed Abo Elfetoh, Professor

CONTACT

01006800910noha_ahmed_re@yahoo.com

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 29, 2017

First Posted

September 7, 2017

Study Start

September 4, 2019

Primary Completion

January 4, 2020

Study Completion

January 4, 2021

Last Updated

April 22, 2019

Record last verified: 2019-01